Dora Lopresto

Dora Lopresto, PhD, currently serves as the Director of Corporate Strategy and M&A at Grünenthal Group since October 2023. Prior to this role, Dora accumulated extensive consulting experience at Boston Consulting Group from September 2019 to October 2023, progressing from Associate to Senior Associate to Consultant. Academic credentials include a PhD in Pharmacology from the University of Cambridge, where research focused on drug-induced vascular injury and included a prestigious AstraZeneca Doctoral Scholarship. Dora's background also features significant roles in various organizations, including a research scientist position at Yale University and a team leader at Cambridge Consulting Network, where strategic marketing initiatives were developed. Notable contributions to campus life during doctoral studies include serving as Vice President of the Corpus Christi College Graduate Body, fostering community engagement and enhancing student support systems.